Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 4, 2009, Pages 260-268

  Czeizel, Andrew E ^a,b  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b NONE   (Hungary)

Author keywords

Congenital abnormalities; Folic acid; Multivitamins; Neural tube defects; Primary prevention

Indexed keywords

ASCORBIC ACID; CALCIUM; CYANOCOBALAMIN; ELEVIT PRENATAL; FOLIC ACID; IRON; MAGNESIUM; MONOGLUTAMATE FOLIC ACID; MULTIVITAMIN; PHOSPHORUS; PLACEBO; PTEROPTIN; PYRIDOXINE; RIBOFLAVIN; UNCLASSIFIED DRUG;

CARDIOVASCULAR MALFORMATION; CLEFT LIP; CLEFT PALATE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOWN SYNDROME; DRUG EFFICACY; DRUG MEGADOSE; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; HYPERHOMOCYSTEINEMIA; LIMB MALFORMATION; MATERNAL CARE; MEDICAL ETHICS; MONOTHERAPY; MORBIDITY; NEURAL TUBE DEFECT; OMPHALOCELE; OPTIMAL DRUG DOSE; PRENATAL CARE; PREVALENCE; PRIMARY HEALTH CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; PYLORUS STENOSIS; REPRODUCTIVE HEALTH; REVIEW; URINARY TRACT MALFORMATION; VITAMIN SUPPLEMENTATION;

CONGENITAL ABNORMALITIES; DIETARY SUPPLEMENTS; FEMALE; FERTILIZATION; FOLIC ACID; HUMANS; HUNGARY; NEURAL TUBE DEFECTS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS; WOMEN'S HEALTH SERVICES;

EID: 65349180183     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20563     Document Type: Review

References (60)

1. Ács N, Bánhidy F, Puho E, Czeizel AE. 2005. Maternal influenza during pregnancy and risk of congenital abnormalities on offspring. Birth Defects Res Part A 73:989-996.
2. Baird CD, Nelson MM, Monie IW, Evans HM. 1954. Congenital cardiovascular anomalies induced by pteroylglutamic acid deficiency during gestation in the rat. Circ Rev 2:544-548.
3. Barkai G, Arbuzova S, Berkenstadt M et al. 2003. Frequency of Down's syndrome and neural-tube defects in the same family. Lancet 361:1331-1335.
4. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
5. Botto LD, Erickson JD, Mulinare J, et al. 2002a. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology 13:485-488.
6. Botto LD, Khoury MJ, Mulinare J, Erickson JD. 1996. Periconceptional multivitamin use and the occurrence of conotruncal heart defects. Results from a population-based case-control study. Pediatrics 98:911-917.
7. Botto LD, Lisi A, Robert-Gnansia E, et al. 2005. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330:571.
8. Botto LD, Mulinare J, Erickson JD. 2000. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 151:878-884.
9. Botto LD, Mulinare J, Erickson JD. 2002b. Occurrence of omphalocele in relation to maternal multivitamin use: a population-based study. Pediatrics 109:904-908.
10. Botto LD, Olney RS, Erickson JD. 2004. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 125C:12-21.
11. Butterworth CE, Tamura T. 1989. Folic acid and toxicity: a brief review. Am J Clin Nutr 50:353-358.
12. Centers for Disease Control and Prevention. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41:1233-1238.
13. Czeizel AE. 1993. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 306:1645-1648.
14. Czeizel AE. 1996. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183.
15. Czeizel AE. 1999. Ten years of experience in the periconceptional care. Eur J Obstet Gynec Reprod Biol 89:43-49.
16. Czeizel AE. 2002. Prevention of oral clefts through the use of folic acid and multivitamin supplements: evidence and gap. In: Wyszynski DF, editor. Cleft lip and palate: from origin to treatment. New York: Oxford University Press. pp. 443-457.
17. Czeizel AE, Dobó M, Vargha P. 2004. Hungarian two-cohort controlled study of periconceptional multivitamin supplementation to prevent certain congenital abnormalities. Birth Defects Research A Clin Mol Teratol 70:853-861.
18. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
19. Czeizel AE, Dudás I, Métneki J. 1994. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 255:131-139.
20. Czeizel AE, Gasztonyi Z, Kuliev A. 2005. Periconceptional clinics: a medical health care infrastructure of new genetics. Fetal Diagn Ther 20:515-518.
21. Czeizel AE, Medveczki E. 2003. No difference in the occurrence of multi-malformed offspring after periconceptional multivitamin supplementation. Obstet Gynec 102:1255-1261.
22. Czeizel AE, Puhó E. 2005. Maternal use of nutritional supplements during the first month of pregnancy and a reduced risk of Down's syndrome. A case-control study. Nutrition 21:698-704.
23. Czeizel AE, Puho HE, Bánhidy F. 2006. No association between periconceptional multivitamin supplementation and risk of multiple congenital abnormalities: a population-based case-control study. Am J Med Genet A 140A:2469-2477.
24. Czeizel AE, Révész C. 1970. Major malformations of the central nervous system in Hungary. Br J Prev Soc Med 24:205-222.
25. Czeizel AE, Sankaranarayanan K. 1984. The load of genetic and partially genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life Mut Res 128:499-503.
26. Czeizel AE, Tímár L, Sárközi A. 1999. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 104:e66.
27. Czeizel AE, Toth M, Rockenbauer M. 1996. A case-control analysis of folic acid supplementation during pregnancy. Teratology 53:345-351.
28. Daly S, Mills JL, Molloy AM, et al. 1997. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350:1666-1669.
29. European Commission Scientific Committee on Food. 1998. Tolerable upper limit levels for vitamins and minerals.
30. Food Safety Authority of Ireland. 2006. Report of the Committee on Folic Acid Food Fortification. Dublin, Ireland.
31. Gueant JL, Gueant-Rodriguez RM, Anello G, et al. 2003. Genetic determination of folate and vitamin B12 metabolism: a common pathway in neural tube defects and Down syndome? Clin Chem Lab Med 41:1473-1477.
32. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. 2000. Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 343:1608-1614.
33. Hobbs CA, Sherman SL, Yi P, et al. 2000. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67:623-630.
34. Institute of Medicine Food and Nutrition Board. 1998. Dietary reference intakes (DRI): risk assessment model establishing upper intake levels. Washington DC: National Academies Press.
35. Iyengar L, Apte SV. 1972. Nutrient stores in human foetal livers. Brit J Nutr 27:313-317.
36. James SJ, Pogribna M, Pogribny IP, et al. 1999. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate-reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495-501.
37. Kapusta L, Haagmans MLM, Steegers EAP, et al. 1999. Congenital heart defects and derangement of homocysteine metabolism. J Pediat 135:773-774.
38. Li DK, Daling JR, Mueller BA, et al. 1995. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:212-218.
39. McPartlin J, Halligan A, Scott JM, et al. 1993. Accelerated folate breakdown in pregnancy. Lancet 341:148-149.
40. Meszavos M, Nagy A, Czeizel AE. 1975. Incidence of congenital heart disease in Hungary. Hum Hered 25:513-9.
41. Monie IW, Nelson MM. 1963. Abnormalities of pulmonary and other vessels in rat fetuses from maternal pteroylglutamic acid deficiency. Anat Rec 147:397-401.
42. Monie IW, Nelson MM, Evans HM. 1954. Abnormalities of the urinary system of rat embryos resulting from maternal pteroylglutamic acid deficiency. Anat Rec 120:119-136.
43. Monie IW, Nelson MM, Evans HM. 1957. Abnormalities of the urinary system of rat embryos resulting from transitory deficiency of pteroylglutamic acid during gestation in the rat. Anat Rec 127:711-724.
44. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338:131-137.
45. Myers MF, Li S, Correa-Villasenor A, et al. 2001. Folic acid supplementation and risk for imperforate anus in China. Am J Epidemiol 154:1051-1056.
46. Nevin NC, Seller MJ. 1990. Prevention of neural tube defect recurrences. Lancet 1:178-179.
47. Scanlon KS, Ferencz C, Loffredo CA, et al. 1998. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 9:95-98.
48. Shaw GW, O'Malley CD, Wasserman CR, Tolarova MM. 1995. Maternal periconceptional use of multivitamin and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59:536-545.
49. Shaw GM, Croen LA, Todoroff K, Tolarova MM. 2000. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies. Am J Med Genet 93:188-193.
50. Smithells RW, Sheppard S, Schorah CJ, et al. 1980. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1:339-340.
51. Smithells RW, Sheppard S, Wild J, Schorah CJ. 1989. Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 2:498-499.
52. Strelling MK. 1976. Transfer of folate to the fetus. Dev Med Child Neurol 28:533-535.
53. Tarusco D. 2004. Folic acid: from research to public health practice. Rome: Rapporti ISTISAN 04/26.
54. Tolarova M. 1982. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 2:217.
55. Van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, et al. 2006. Maternal MTHFR 677C>T is a risk factors for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 27:981-987.
56. Wald NJ, Law MR, Morris JK, Wald DS. 2001. Quantifying the effect of folic acid. Lancet 358:2069-2073.
57. Warkany J, Beaudry PH, Hornstein S. 1959. Attempted abortion with 4-aminopteroylglutamic acid (aminopterin): malformations of the child. Am J Dis Child 97:274-281.
58. Werler MM, Hayes C, Louik C. 1999. Multivitamin use and risk of birth defects. Am J Epidemiol 150:675-682.
59. Yang Q, Khoury MJ, Olney RS, Mulinare J. 1997. Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring? Epidemiology 8:157-161.
60. Yuskin N, Honein MA, Moore CA. 2005. Reported multivitamin supplementation and the occurrence of multiple congenital anomalies. Am J Med Genet Part A 136A:1-7.